Want to see VERA full AI Analyst Report?
Vera Therapeutics (VERA) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Atacicept | Iga Nephropathy (Igan), Berger Disease | Phase II | Recruiting | Monthly Dosing of Atacicept in IgAN | May 13, 2025 | ― |
| Atacicept | Fsgs, Igan, Pmn, Nephrotic Syndrome, Mcd | Phase II | Recruiting | Atacicept in Multiple Glomerular Diseases | May 13, 2025 | ― |
| Atacicept 150 Mg | Iga Nephropathy (Igan), Berger Disease, Renal And Urinary Disorders | Phase II | Enrolling By Invitation | A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept | Oct 03, 2024 | ― |
| Atacicept | Lupus Nephritis (Ln) | Phase III | Withdrawn | Atacicept in Subjects With Active Lupus Nephritis (COMPASS) | Nov 02, 2022 | ― |
| Atacicept | Iga Nephropathy, Berger Disease | Phase III | Active Not Recruiting | Atacicept in Subjects With IgA Nephropathy | Jan 11, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Atacicept | Phase II | Iga Nephropathy (Igan), Berger Disease | Recruiting | Monthly Dosing of Atacicept in IgAN | May 13, 2025 | ― |
| Atacicept | Phase II | Fsgs, Igan, Pmn, Nephrotic Syndrome, Mcd | Recruiting | Atacicept in Multiple Glomerular Diseases | May 13, 2025 | ― |
| Atacicept 150 Mg | Phase II | Iga Nephropathy (Igan), Berger Disease, Renal And Urinary Disorders | Enrolling By Invitation | A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept | Oct 03, 2024 | ― |
| Atacicept | Phase III | Lupus Nephritis (Ln) | Withdrawn | Atacicept in Subjects With Active Lupus Nephritis (COMPASS) | Nov 02, 2022 | ― |
| Atacicept | Phase III | Iga Nephropathy, Berger Disease | Active Not Recruiting | Atacicept in Subjects With IgA Nephropathy | Jan 11, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vera Therapeutics, Inc. (VERA) have in its pipeline
Vera Therapeutics VERA is currently developing the following drugs: Atacicept, Atacicept 150 Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.